Desmoplastic trichoepithelioma (DTE) is a histologic variant of TE that merits additional description.
Desmoplastic trichoepithelioma versus morphoeic basal cell carcinoma: a critical reappraisal of histomorphological and immunohistochemical criteria for differentiation.
The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
Histopathological differential diagnosis should be fibrosing basal cell carcinoma desmoplastic trichoepithelioma
microcystic adnexal carcinoma.
Eighteen cases of morphoeic basal cell carcinoma and 19 cases of desmoplastic trichoepithelioma
were studied by Costache et al.
It is of limited value in differentiating infiltrative BCC from desmoplastic trichoepithelioma
(DTE), although BCC shows diffuse staining and DTE shows partial staining 16.
Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma.
Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma.
Differentiation of Morpheaform/Infiltrating Basal Cell Carcinoma (BCC) and Desmoplastic Trichoepithelioma (DTE) Stain BCC DTE p75 (tumor cells) - + PHLDA1 (tumor cells) - + [CK20.
Generalized trichoepitheliomas with alopecia and myasthenia gravis: clinicopathologic and immunohistochemical study and comparison with classic and desmoplastic trichoepithelioma